Navigation Links
Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
Date:2/4/2010

Broad business development experience in worldwide specialty chemicals industry to help accelerate commercial plans.

Marlborough, MA (Vocus) February 4, 2010 -- Qteros, Inc., a leading developer of second-generation technology solutions for the biofuels industry based on its unique Q Microbe ™ platform, announced today that Mick Sawka has joined the company as Vice President, Business Development, to help accelerate the company’s technology and commercial initiatives in the worldwide cellulosic ethanol marketplace.

Mr. Sawka’s 19-year experience in the specialty chemicals industry includes negotiating and leading numerous large-scale strategic partnerships, alliances, and acquisitions as well as complex product introductions throughout the world. Additionally, Sawka has been responsible for the development of numerous technology platforms and associated strategic business plans within both development-stage and large-scale specialty chemical organizations.    

Mr. Sawka joins Qteros from Microbia, Inc. where he led business development efforts for this developer of unique bio-based specialty chemicals directed at large-scale industrial applications. Prior to Microbia, Mr. Sawka spent six years at Cabot Corporation, most recently serving as Director of New Business Development and R&D for Cabot’s Performance Products Business Group. Prior to Cabot, Sawka spent 11 years at 3M in various senior level business and product development positions throughout the company. Mr. Sawka holds a BS in Chemical Engineering from Stanford University, an MS in Chemical Engineering from MIT (including assignments in Dr. Robert Langer’s lab), and a Masters in International Management from The University of St. Thomas in St. Paul, Minnesota.

“Having worked closely with Mick at Microbia, I’m thrilled to have him join us to help at this important stage of our development and believe he brings the kind of energy, industry experience, and business creativity we need at Qteros to help catalyze our strategic corporate development efforts”, stated John McCarthy, President and CEO of Qteros. “Mick’s experience and success helping lead innovative product development within large-scale industrial chemicals companies will bring a great complement to our team as we accelerate the development of important industrial partnerships for Qteros.”

“Qteros is a dynamic organization with a truly disruptive technology platform, and I am thrilled to have the opportunity to help build the partnerships that will transform Qteros’ scientific achievements into commercial reality within the emerging worldwide biofuels industry,” stated Sawka.    

About Qteros, Inc.
Qteros is committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The company is currently in the process of scaling up a unique microbial solution for the highly efficient and cost-effective conversion of non-food biomass into clean transportation fuel. The company’s patented Q Microbe™ system converts a wide array of cellulosic biomass directly into ethanol in a single process, consolidating enzymatic hydrolysis and fermentation, largely eliminating costly exogenous enzymes and associated pretreatments, and greatly simplifying the entire production process. This process is commonly referred to as consolidated bioprocessing. Qteros’s scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world's growing energy needs. Qteros has been funded by some of the leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, visit www.Qteros.com.

###

Read the full story at http://www.prweb.com/releases/Qteros/Mick_Sawka/prweb3566374.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Catilin Contributes Key Extraction, Sequestration and Conversion Technologies to NAABB Consortium Developing Algal Biofuels
2. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
3. Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae
4. Cellulosic Biofuels Leader Qteros Adds Key Positions
5. Global Biofuels Growth to Double by 2015
6. New Generation Biofuels Receives NASDAQ Notice of Noncompliance with Continued Listing Requirements
7. Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.
8. Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production
9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
10. Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
11. New Generation Biofuels Signs Letter of Intent with Instituto Costarricense de Electricidad (ICE) of Costa Rica
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
(Date:6/15/2017)... ... June 15, 2017 , ... DuPont Industrial ... will be speaking at Bloomberg’s 2017 Sustainable Business Summit: Seattle this ... and sustainability officials on a panel titled “Developing a Corporate Renewables Strategy.” ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand Board ... announces that they’re co-hosting a delegation from Thailand at BIO 2017 in San ... industry gathering in the world, regroups more than 1,100 biotech companies, academic institutions, ...
(Date:6/14/2017)... ... 14, 2017 , ... Cynvenio Biosystems, Inc. a ... distribution agreements for Cynvenio’s ClearID line of blood tests that support targeted treatment selection ... ClearID available immediately in Israel, Greece, Argentina, and South Korea. , ...
(Date:6/14/2017)... ... June 14, 2017 , ... ... 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) ... diseases, including rheumatoid arthritis and systemic lupus erythematosus. Fifty-six (56) healthy ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):